Literature DB >> 12880489

Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.

Joseph Pulvirenti1, Patricia Herrera, Priya Venkataraman, Nooruzsabha Ahmed.   

Abstract

Since the advent of highly active antiretroviral therapy (HAART), the incidence of opportunistic infections (OI) in patients with HIV has markedly decreased. Despite this, there are still large numbers of Pneumocystis carinii pneumonia (PCP) cases at Cook County Hospital (CCH). To better understand this patient group, we performed a retrospective chart review of 120 pathologically proven cases of PCP from January 1998 to June 2001. One hundred four patients were included in the study. Sixty-nine percent of our patients were active substance abusers and 50% had previous knowledge of HIV disease. Of our patients, fewer than 5% were on HAART or PCP prophylaxis on study admission. The overall mortality rate was 14%. Of discharged patients, 65% were placed on HAART therapy and 59% of these achieved a viral load of less than 1000 copies per milliliter in the year postdischarge. Patients who failed to achieve a viral load less than 1000 copies per milliliter were more likely active substance abusers or had a viral load greater than 100,000 copies per milliliter prior to study admission. Our study shows that patients are still being admitted with PCP in the HAART era. Active substance abuse and failure to recognize HIV status contributed heavily to this late presentation of HIV disease. An aggressive approach toward HIV identification and substance abuse treatment may decrease admissions to the hospital for PCP and improve response to HAART therapy.

Entities:  

Mesh:

Year:  2003        PMID: 12880489     DOI: 10.1089/108729103322108139

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  17 in total

1.  Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods.

Authors:  G W Procop; S Haddad; J Quinn; M L Wilson; N G Henshaw; L B Reller; R L Artymyshyn; M T Katanik; M P Weinstein
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

Authors:  Lisa R McTaggart; Nancy L Wengenack; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

Review 3.  HIV-associated lung infections and complications in the era of combination antiretroviral therapy.

Authors:  Kristina Crothers; Bruce W Thompson; Kathryn Burkhardt; Alison Morris; Sonia C Flores; Philip T Diaz; Richard E Chaisson; Gregory D Kirk; William N Rom; Laurence Huang
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: an update.

Authors:  Deepa G Lazarous; Anne E O'Donnell
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 5.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

Authors:  Peter D Walzer; Hannah E R Evans; Andrew J Copas; Simon G Edwards; Alison D Grant; Robert F Miller
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

7.  Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.

Authors:  T Fauchier; L Hasseine; M Gari-Toussaint; V Casanova; P M Marty; C Pomares
Journal:  J Clin Microbiol       Date:  2016-03-23       Impact factor: 5.948

8.  Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study.

Authors:  Matthew W Fei; Catherine A Sant; Eunice J Kim; Alexandra Swartzman; J Lucian Davis; Leah G Jarlsberg; Laurence Huang
Journal:  Scand J Infect Dis       Date:  2009

9.  The prevalence of laboratory-confirmed Pneumocystis jirovecii in HIV-infected adults in Africa: A systematic review and meta-analysis.

Authors:  Nicola K Wills; David S Lawrence; Elizabeth Botsile; Mark W Tenforde; Joseph N Jarvis
Journal:  Med Mycol       Date:  2021-07-14       Impact factor: 4.076

10.  Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.

Authors:  Christian M Parobek; Linda Y Jiang; Jaymin C Patel; Miriam J Alvarez-Martínez; Jose M Miro; William Worodria; Alfred Andama; Serena Fong; Laurence Huang; Steven R Meshnick; Steve M Taylor; Jonathan J Juliano
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.